[Mechanism of miR-221 contributes to gefitinib resistance in PC-9 cells]
1Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Abstract:
Objective: To investigate the effect of microRNA-221 (miR-221) overexpression on gefitinib resistance in PC-9 cells and study its underlying mechanisms. Methods: PC-9 cells were transfected with LV-NC and LV-miR-221 to establish cell stabilizing strains (PC-9/NC and PC-9/miR-221), then they were used to detect the relative expression of miR-221 and apoptotic protease activating factor-1 (APAF-1) mRNA by real-time fluorescence quantitative PCR (qRT-PCR). The effects of gefitinib (0-4 μmol/L) on the growth and proliferation of cell stabilizing strains were detected by CCK-8 Assay. After gefitinib treatment, cell apoptosis was detected by Flow Cytometry Assays. The expression of epidermal growth factor receptor (EGFR), phosphorylated epidermal growth factor receptor (p-EGFR), APAF-1 and cleaved cysteinyl aspartate specific proteinase-3 (Cleaved-caspase-3) were detected by Western blot. Dual-Luciferase Reporter Assay was used to evaluate the relationship between APAF-1 and miR-221. Results: The relative expression of miR-221 in PC-9/NC cells was significantly lower than that in PC-9/miR-221 cells[(1.00±0.082) vs (40.24±0.017)](P<0.01). The half maximal inhibitory concentration (IC(50)) in PC-9/NC cells was significantly lower than that in PC-9/miR-221 cells[(IC(50)=0.1 μmol/L) vs (IC(50)>4 μmol/L)](P<0.05). Apoptosis rate of PC-9/NC cell was significantly higher than PC-9/miR-221[(33.42±4.28)% vs (10.27±1.12)%](P<0.05); APAF-1 mRNA expression was significantly higher in PC-9/NC cells than PC-9/miR-221[(1.000+ 0.069) vs (0.701±0.072)](P<0.05), and the expression of APAF-1 protein in PC-9/NC cells was significantly higher than that of PC-9/miR-221 cells. The dual luciferase reporter gene results showed that miR-221a inhibited luciferase activity significantly stronger than transfected miRNA negative control group after co-transfection of luciferase plasmids pmir-REPORT-APAF-1-wt and miR-221a mimics (P<0.01). p-EGFR was down-regulated in both PC-9/NC and PC-9/miR-221 cells after treatment with gefitinib. APAF-1 and Cleaved-caspase-3 proteins were significantly down-regulated in PC-9/miR-221 cells compared with PC-9/NC cells, while APAF-1 and Cleaved-caspase-3 proteins were up-regulated in PC-9/NC cells treated with gefitinib compared with PC-9/miR-221 cells (P<0.05). Conclusion: miR-221 induces resistance to gefitinib in PC-9 cells by downregulating APAF-1 expression.
Insights
MicroRNA-221 (miR-221) overexpression induces gefitinib resistance in PC-9 cells by downregulating apoptotic protease activating factor-1 (APAF-1). This finding offers insights into overcoming drug resistance in non-small cell lung cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Gefitinib is a targeted therapy for non-small cell lung cancer (NSCLC) but resistance limits its efficacy.
- MicroRNAs play crucial roles in gene regulation and cancer development, including drug resistance.
Purpose of the Study:
- To investigate the role of microRNA-221 (miR-221) in gefitinib resistance in PC-9 NSCLC cells.
- To elucidate the underlying molecular mechanisms, focusing on apoptotic protease activating factor-1 (APAF-1).
Main Methods:
- PC-9 cells were stably transfected to overexpress miR-221 (PC-9/miR-221) or a control (PC-9/NC).
- Quantitative real-time PCR (qRT-PCR) and Western blot were used to assess miR-221, APAF-1, and related protein expression.
- Cell proliferation (CCK-8 assay), apoptosis (Flow Cytometry), and target validation (Dual-Luciferase Reporter Assay) were performed.
Main Results:
- miR-221 overexpression significantly increased gefitinib resistance (higher IC50) and reduced apoptosis in PC-9 cells.
- miR-221 significantly downregulated both APAF-1 mRNA and protein expression, confirmed by luciferase assays.
- Downregulation of APAF-1 and cleaved caspase-3 was observed in miR-221 overexpressing cells, indicating impaired apoptosis.
Conclusions:
- MicroRNA-221 overexpression confers gefitinib resistance in PC-9 cells.
- This resistance is mediated by the downregulation of APAF-1, a key regulator of apoptosis.
- Targeting miR-221 or restoring APAF-1 expression may represent therapeutic strategies to overcome gefitinib resistance.
More Related Videos
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Resistivity
Resistance
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Equivalent Resistance


